Capsa Healthcare (“Capsa” or the “Company”), a portfolio company of Levine Leichtman Capital Partners, LLC (“LLCP”), announced today that it has acquired Tryten Technologies Inc. (“Tryten”).

Based in Vancouver, British Columbia, Tryten is a market-leading provider of lightweight, non-powered carts predominantly focused on enabling telehealth solutions. Tryten has developed advanced and high-quality technology solutions that allow healthcare providers to better serve patients through bedside virtual care, remote patient monitoring, medical device affixtures and patient self-registration/check-in. The specialized patient care offered through Tryten’s products leads to improved patient engagement and satisfaction while also enhancing hospital staff utilization.

Capsa is a leading provider of innovative, highly engineered, workflow products that increase efficiency and reduce costs, enhance medication security and tighten inventory control across healthcare settings worldwide. The Company’s core offerings, which include mobile workstations, medication management solutions and pharmacy automation products, are sold to a diverse set of end customers, including leading health systems, senior care communities, and major retail and institutional pharmacies. Founded in 1958 and headquartered in Columbus, Ohio, Capsa has additional production facilities in Portland, Oregon, Agua Prieta, Mexico, and Waalwijk, Netherlands. Capsa has grown steadily through a combination of internal development and the acquisition of complementary product brands and technology platforms.

“We are excited to welcome Tryten to the Capsa family,” said Eric Webb, Chief Executive Officer of Capsa. “Tryten’s products are highly regarded by customers and add an exciting solution to Capsa’s portfolio that uniquely positions us to serve our healthcare provider partners with the widest product portfolio available to further provide expanded virtual care, improved patient engagement, and efficient mobility for medical devices.”

“Joining the Capsa platform is an exciting opportunity for Tryten and our customers.” said Tony Janzen, Chief Executive Officer of Tryten. “Capsa’s strong reputation, expertise and scale in the healthcare industry will allow us to continue to introduce and deliver new technology solutions.”

Andrew Schwartz, a Partner at LLCP, said, “We are pleased by the continued momentum of Capsa’s M&A strategy as it further enhances its ability to address key industry demands. Tryten’s product portfolio is highly complementary to Capsa’s core acute care offerings and expands Capsa’s addressable market opportunity to include a number of new and exciting segments. We look forward to the continued growth of Capsa.”

Tryten is Capsa’s fifth acquisition during LLCP’s ownership.

Capsa is a portfolio company of Levine Leichtman Capital Partners VI, L.P.